Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

U.S. Physical Therapy Inc. (USPH) Stock Falls on Q1 2026 Earnings

None

U.S. Physical Therapy Inc. (USPH) reported first-quarter 2026 results. Total revenue was $198.3 million, up 7.9% year over year, versus an expected $205.0 million.

  • Gross profit: $32.8 million (+5.4% YoY).
  • Operating profit: $12.5 million (-36.5% YoY).
  • Net income attributable to common shareholders: $5.0 million (-49.1% YoY).
  • Diluted earnings per share: -$0.12 (-115.0% YoY).
  • Cost of sales: $165.5 million (+14.1% YoY).
  • Cash flow and capital spending:

  • Cash from operating activities: $3.8 million (-181.5% YoY).
  • Purchases of property, plant and equipment: $5.4 million (+108.3% YoY).
  • Cash and cash equivalents at quarter end: $28.4 million (-27.4% YoY).
  • Total liabilities: $459.2 million (+9.2% YoY).
  • Results versus expectations and market reaction:

  • Revenue missed the estimate of $205.0 million.
  • Reported diluted EPS of -$0.12 missed the estimate of $0.56.
  • Shares were down 4.18% since market close.
  • Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

    U.S. Physical Therapy Inc. Insider Trading Activity

    USPH Insider Trades

    U.S. Physical Therapy Inc. insiders have traded $USPH stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

    Here’s a breakdown of recent trading of $USPH stock by insiders over the last 6 months:

    • KATHLEEN A GILMARTIN purchased 4,000 shares for an estimated $276,000
    • RICHARD BINSTEIN (EVP Gen'l Counsel & Secretary) sold 3,000 shares for an estimated $244,920
    • GRAHAM D. REEVE (COO) has made 0 purchases and 2 sales selling 1,405 shares for an estimated $104,965.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

    U.S. Physical Therapy Inc. Hedge Fund Activity

    We have seen 91 institutional investors add shares of U.S. Physical Therapy Inc. stock to their portfolio, and 129 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

    U.S. Physical Therapy Inc. Analyst Ratings

    Wall Street analysts have issued reports on $USPH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Barrington Research issued a "Outperform" rating on 01/05/2026
    • JP Morgan issued a "Overweight" rating on 11/24/2025

    To track analyst ratings and price targets for U.S. Physical Therapy Inc., check out Quiver Quantitative's $USPH forecast page.

    U.S. Physical Therapy Inc. Price Targets

    Multiple analysts have issued price targets for $USPH recently. We have seen 3 analysts offer price targets for $USPH in the last 6 months, with a median target of $102.0.

    Here are some recent targets:

    • Brian Tanquilut from Jefferies set a target price of $102.0 on 03/10/2026
    • Michael Petusky from Barrington Research set a target price of $103.0 on 02/20/2026
    • Benjamin Rossi from JP Morgan set a target price of $100.0 on 11/24/2025

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles